SLM Corp Reports Strong 2025 Performance, Significant Share Buybacks, and High Executive Payouts in Definitive Proxy
SLM sits 32% above its 52-week low of $17.77.
Summary
SLM Corp's definitive proxy statement reveals strong 2025 financial results, significant share repurchases, and high executive performance-based compensation payouts, alongside details for the upcoming annual shareholder meeting.
Key Events · Corporate Governance and Compliance · SLM
-
Strong 2025 Financial Performance
SLM Corp reported a significant increase in 2025 Net Income to $729 million (up from $590 million in 2024) and GAAP Diluted EPS of $3.46 (up from $2.68 in 2024). Private Education Loan Originations grew by 6% to $7.4 billion.
-
Substantial Share Repurchases
The company executed repurchases of 12.8 million shares in 2025, resulting in an approximate 6% reduction in total common stock outstanding since January 1, 2025, demonstrating a robust capital return program.
-
High Executive Performance Payouts
Performance Stock Units (PSUs) granted in 2023 vested in February 2026 at 176% of target, reflecting strong relative Total Shareholder Return (TSR) over the three-year performance period.
-
Executive Promotions Announced
Peter M. Graham was appointed Co-President and Chief Financial Officer, and Kerri A. Palmer was appointed Co-President and Head of Financial Services, both effective April 22, 2026.
Analysis · SLM · Finance
This definitive proxy statement highlights SLM Corp's robust financial and operational performance in 2025, marked by substantial increases in net income and EPS, and a 6% growth in loan originations. The company's commitment to shareholder returns is evident through the repurchase of 12.8 million shares, a significant capital return. The high payout of 176% for 2023 Performance Stock Units further underscores strong executive performance aligned with shareholder value creation. These disclosures, combined with details on corporate governance and recent executive promotions, paint a positive picture of the company's health and strategic direction.
At the time of this filing, SLM was trading at $23.43 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $17.77 to $34.97. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.